KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Amortizatization of Intangibles: 2009-2025

Historic Amortizatization of Intangibles for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Sep 2025 value amounting to $978,000.

  • Biomarin Pharmaceutical's Amortizatization of Intangibles fell 49.61% to $978,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 40.21%. This contributed to the annual value of $8.3 million for FY2024, which is 9.57% down from last year.
  • According to the latest figures from Q3 2025, Biomarin Pharmaceutical's Amortizatization of Intangibles is $978,000, which was down 27.82% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Amortizatization of Intangibles ranged from a high of $2.6 million in Q2 2023 and a low of -$1.9 million during Q4 2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $2.0 million (2023), whereas its average is $1.9 million.
  • In the last 5 years, Biomarin Pharmaceutical's Amortizatization of Intangibles slumped by 5,577.27% in 2021 and then skyrocketed by 435.02% in 2023.
  • Over the past 5 years, Biomarin Pharmaceutical's Amortizatization of Intangibles (Quarterly) stood at -$1.9 million in 2021, then surged by 137.21% to $698,000 in 2022, then surged by 250.57% to $2.4 million in 2023, then declined by 29.46% to $1.7 million in 2024, then tumbled by 49.61% to $978,000 in 2025.
  • Its Amortizatization of Intangibles stands at $978,000 for Q3 2025, versus $1.4 million for Q2 2025 and $1.4 million for Q1 2025.